DexCom Inc
(BSP:D1EX34)
R$
9.65
0 (0%)
Market Cap: 188.46 Bil
Enterprise Value: 189.06 Bil
PE Ratio: 48.19
PB Ratio: 15.88
GF Score: 74/100 Dexcom Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 13, 2021 / 06:00PM GMT
Release Date Price:
R$14.07
(-4.45%)
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst
Good afternoon and thank you for joining us for the third day of the 2021 Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst and a member of the healthcare research team here at Morgan Stanley. It's my pleasure to have DexCom Chairman, President and CEO, Kevin Sayer, with us today.
And quickly, before we begin, I'll run through our disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
And with that, Kevin, thank you for joining us today.
Kevin Ronald Sayer
DexCom, Inc. - Executive Chairman, CEO & President
Well, thank you for having me. It's a pleasure to be here.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot